Trupanion (NASDAQ:TRUP) was upgraded by investment analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Tuesday.
Other research analysts have also recently issued reports about the company. Zacks Investment Research raised Trupanion from a “hold” rating to a “buy” rating and set a $29.00 target price for the company in a research report on Wednesday, October 4th. Canaccord Genuity reissued a “buy” rating and set a $35.00 price objective (up from $29.00) on shares of Trupanion in a report on Tuesday, October 31st. Finally, CL King began coverage on Trupanion in a report on Tuesday, November 21st. They set a “neutral” rating for the company. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Trupanion currently has a consensus rating of “Buy” and an average price target of $28.83.
Trupanion (NASDAQ:TRUP) traded up $0.35 on Tuesday, hitting $32.01. The stock had a trading volume of 102,080 shares, compared to its average volume of 162,575. Trupanion has a 12 month low of $13.71 and a 12 month high of $33.00. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.87 and a quick ratio of 1.87.
In related news, Director Murray B. Low sold 3,000 shares of Trupanion stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $31.14, for a total value of $93,420.00. Following the completion of the sale, the director now directly owns 197,281 shares in the company, valued at $6,143,330.34. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Tricia Plouf sold 1,000 shares of Trupanion stock in a transaction dated Tuesday, November 7th. The stock was sold at an average price of $32.11, for a total value of $32,110.00. Following the completion of the sale, the chief financial officer now owns 14,000 shares of the company’s stock, valued at $449,540. The disclosure for this sale can be found here. Over the last quarter, insiders sold 118,539 shares of company stock valued at $3,123,783. Corporate insiders own 31.24% of the company’s stock.
A number of institutional investors and hedge funds have recently modified their holdings of TRUP. JPMorgan Chase & Co. bought a new position in Trupanion during the third quarter worth about $143,000. Bank of Montreal Can boosted its holdings in Trupanion by 309.2% during the second quarter. Bank of Montreal Can now owns 9,044 shares of the financial services provider’s stock worth $201,000 after buying an additional 6,834 shares during the last quarter. Voya Investment Management LLC bought a new position in Trupanion during the second quarter worth about $215,000. Oppenheimer Asset Management Inc. bought a new position in Trupanion during the third quarter worth about $221,000. Finally, Alliancebernstein L.P. boosted its holdings in Trupanion by 1.2% during the first quarter. Alliancebernstein L.P. now owns 16,700 shares of the financial services provider’s stock worth $237,000 after buying an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 63.25% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was published by Week Herald and is the property of of Week Herald. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://weekherald.com/2017/12/14/trupanion-trup-rating-increased-to-hold-at-bidaskclub.html.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.